Kamada Ltd (KMDA) is scheduled to announce Q1 2022 earnings on Tuesday, 17 May 2022, before market open. Wallstreet estimates an EPS of $0.03 and a revenue of $32.40 M in the upcoming results. Historically, Kamada Ltd beated EPS estimates 40% of the times.
About Kamada Ltd
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment develops, manufactures and sells plasma-derived therapeutics products. The Distribution segment supplies plasma based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Ness Ziona, Israel.